QIAGEN(QGEN)
Search documents
QIAGEN(QGEN) - 2022 Q2 - Earnings Call Presentation
2022-07-29 03:29
Q2 2022 results Solid results with 10% CER sales growth in non-COVID portfolios Forward looking and intended use statements Safe Harbor Statement: This presentation contains both historical and forward-looking statements. All statements other than statements of historical fact are, or may be, deemed to be forward looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. To the extent that any ...
QIAGEN(QGEN) - 2022 Q1 - Earnings Call Transcript
2022-04-28 20:15
QIAGEN N.V. (NYSE:QGEN) Q1 2022 Earnings Conference Call April 28, 2022 10:00 AM ET Company Participants John Gilardi - VP of Corporate Communications and IR Thierry Bernard - CEO Roland Sackers - CFO Conference Call Participants Patrick Donnelly - Citi Dan Arias - Stifel Derik De Bruin - Bank of America Matt Sykes - Goldman Sachs Dan Brennan - Cowen Casey Woodring - JPMorgan Jack Meehan - Nephron Research Operator Ladies and gentlemen, thank you for standing by. I am Elaine, your PGI call operator. Welcome ...
QIAGEN(QGEN) - 2021 Q4 - Earnings Call Presentation
2022-02-16 13:09
Q4 and full-year 2021 results Exceeded outlook with strong performance from non-COVID product groups Q4 and Full-year 2021 results Sample to Insight Forward looking and intended use statements Safe Harbor Statement: This presentation contains both historical and forward-looking statements. All statements other than statements of historical fact are, or may be, deemed to be forward looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. ...
QIAGEN(QGEN) - 2021 Q4 - Earnings Call Transcript
2022-02-09 19:54
QIAGEN N.V. (NYSE:QGEN) Q4 2021 Earnings Conference Call February 9, 2022 9:00 AM ET Company Participants John Gilardi - Vice President of Corporate Communications & Investor Relations Thierry Bernard - Chief Executive Officer Roland Sackers - Chief Financial Officer Conference Call Participants Patrick Donnelly - Citi Tycho Peterson - JPMorgan Daniel Wendorff - ODDO BHF Jack Meehan - Nephron Research Dan Arias - Stifel Falko Friedrichs - Deutsche Bank Operator Please standby, we're about to begin. Ladies a ...
QIAGEN (QGEN) presents at 40th JPMorgan Annual Healthcare Conference (Slideshow)
2022-01-11 18:11
Sample to Insight | --- | --- | --- | --- | |-------------------------------------------------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Emerging from change | | | | | with a strengthened profile | | | | | J.P. Morgan Healthcare Conference January 2022 | | | | | Thierry Bernard Chief Executive Officer | | | | Forward looking and intended use statements Safe Harbor Statement: This presentation contains both historical and forward-looking statements. All statements ...
QIAGEN(QGEN) - 2021 Q3 - Earnings Call Transcript
2021-11-04 19:55
QIAGEN N.V. (NYSE:QGEN) Q3 2021 Earnings Conference Call November 4, 2021 9:30 AM ET Company Participants John Gilardi - Vice President, Head-Corporate Communications and Investor Relations Thierry Bernard - Chief Executive Officer Roland Sackers - Chief Financial Officer Conference Call Participants Falko Friedrichs - Deutsche Bank Tycho Peterson - JPMorgan Daniel Wendorff - Oddo BHF Derik de Bruin - Bank of America Scott Bardo - Berenberg Jack Meehan - Nephron Dan Brennan - Cowen Operator Ladies and gentl ...
QIAGEN (QGEN) Investor Presentation - Slideshow
2021-05-18 22:21
Sample to Insight Investor Presentation Q2 2021 Thierry Bernard Chief Executive Officer Forward looking and intended use statements Safe Harbor Statement: This presentation contains both historical and forward-looking statements. All statements other than statements of historical fact are, or may be, deemed to be forward looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. To the extent t ...
QIAGEN(QGEN) - 2021 Q1 - Earnings Call Transcript
2021-05-05 05:28
QIAGEN N.V. (NYSE:QGEN) Q1 2021 Earnings Conference Call May 4, 2021 9:00 AM ET Company Participants John Gilardi – Vice President, Head-Corporate Communications and Investor Relations Thierry Bernard – Chief Executive Officer Roland Sackers – Chief Financial Officer Phoebe Loh – Senior Director-Investor Relations Conference Call Participants Patrick Donnelly – Citi Daniel Wendorff – Commerzbank Scott Bardo – Berenberg Doug Schenkel – Cowen John Sourbeer – UBS Falko Friedrichs – Deutsche Bank Brian Weinstei ...
QIAGEN(QGEN) - 2021 Q1 - Earnings Call Presentation
2021-05-04 16:42
Sample to Insight First quarter 2021 results May 4, 2021 Forward looking and intended use statements Safe Harbor Statement: This presentation contains both historical and forward-looking statements. All statements other than statements of historical fact are, or may be, deemed to be forward looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. To the extent that any of the statements conta ...
QIAGEN(QGEN) - 2020 Q4 - Earnings Call Transcript
2021-02-10 20:10
QIAGEN N.V. (NYSE:QGEN) Q4 2020 Earnings Conference Call February 10, 2021 9:00 AM ET Company Participants John Gilardi - Vice President, Head of Corporate Communications & Investor Relations Thierry Bernard - Chief Executive Officer Roland Sackers - Chief Financial Officer Conference Call Participants Jack Meehan - Nephron Research Daniel Wendorff - Commerzbank Brian Weinstein - William Blair Scott Bardo - Berenberg Doug Schenkel - Cowen Steve Beuchaw - Wolfe Research Derik De Bruin - Bank of America Dan ...